跳至主要内容
临床试验/NCT04421911
NCT04421911已完成3 期

A Study to Comparing the Efficacy and Safety of the Ketoprofen and Diclofenac in Patients With Osteoarthritis

Handok Inc.9 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2020年3月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Handok Inc.
入组人数
236
试验地点
9
主要终点
Mean change in walking arthritis pain intensity score

研究概览

简要总结

Primary objective:

• To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of primary endpoint : Mean change in walking arthritis pain intensity score

Secondary objectives:

  • To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of secondary endpoints.
  • To assess safety and tolerability of the Ketoprofen compared with Diclofenac based on the nature and frequency of adverse events in treatment groups

详细描述

This trial is designed as an open-label, multicenter, randomized, clinical study for assessment of efficacy and safety of Ketoprofen plaster and Diclofenac plaster in patients with osteoarthritis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 40-75 years
  • Compliance to ACR diagnostic criteria of OA of the knee
  • Patients with Kellgren-Lawrence grade 1-3
  • Index knee pain should be ≥40 mm on VAS (100mm) scale

排除标准

  • Intolerance or allergic reactions to the study therapy
  • Usage of NSAIDs within 3 days
  • Open skin lesions or dermatological conditions at the site of plaster application
  • Surgery or major trauma of the index knee within the previous 12 months
  • Pregnant or breast-feeding women
  • Alcohol addiction, drug addiction or drug abuse in the past

研究组 & 干预措施

ketoprofen

Experimental

干预措施: Ketoprofen topical (Drug)

Diclofenac

Active Comparator

干预措施: Diclofenac Topical (Drug)

结局指标

主要结局

Mean change in walking arthritis pain intensity score

时间窗: 3 weeks

Pain will be assessed by a horizontal 100 mm Visual Analogue Scale (VAS)

次要结局

  • Mean change in spontaneous arthritis pain intensity score(3 weeks)
  • Knee injury and Osteoarthritis Outcome Score (KOOS)(3 weeks)
  • Global Impression of Improvement (PGI-I)(3 weeks)
  • Adverse events(3 weeks)

研究者

发起方
Handok Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验

A Study to Assess Efficacy and Safety of the... | 临床试验